Log in to your Inderes Free account to see all free content on this page.
Genetic Analysis
0.64 NOK
-3.03 %
Less than 1K followers
GEAN
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Genetic Analysis
P/B
Median 2021-2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share price (NOK) | 6.24 | 2.07 | 0.85 | 0.51 | 0.70 |
| Shares | 24.9 | 24.9 | 38.2 | 49.4 | 69.1 |
| Market cap | 155.5 | 51.6 | 32.5 | 25.2 | 48.4 |
| Enterprise value | 110.1 | - | - | - | - |
| EV/S | 16.2 | - | - | - | - |
| EV/EBITDA | neg. | - | - | - | - |
| EV/EBIT | neg. | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. |
| P/B | 2.16 | 1.17 | 1.02 | 1.12 | 1.79 |
| P/S | 22.9 | 4.6 | 2.3 | 1.6 | 2.9 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 86.3 % | 68.5 % | 59.8 % | 53.1 % | 51.6 % |
| Gearing ratio | 2.0 % | 16.6 % | 17.0 % | 37.1 % | 23.6 % |
Login required
This content is only available for logged in users